US Stock MarketDetailed Quotes

PTGX Protagonist Therapeutics

Watchlist

52.650
-0.400-0.75%

Close Mar 21 16:00 ET

52.450
-0.200-0.38%

Post 20:01 ET

3.23BMarket Cap12.45P/E (TTM)

Protagonist Therapeutics Stock Forum

Teddy123

Mar 10 20:18

Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to Transform the Treatment Paradigm for Patients With Ulcerative Colitis

$Protagonist Therapeutics (PTGX.US)$
Protagonist Reports Positive Top Line Results From Phase 2b Study of Icotrokinra Showing Potential to Transform the Treatment Paradigm for Patients With Ulcerative Colitis

Teddy123

Mar 8 22:55

Icotrokinra Clinical Study Results Demonstrate Its Potential to Shift Treatment Paradigm and Set a New Standard for Treatment in Plaque Psoriasis

$Protagonist Therapeutics (PTGX.US)$
Can This New Oral Psoriasis Drug Replace Injectable Treatments? Phase 3 Data Shows Remarkable 46% Complete Clearance

Teddy123

Mar 3 19:49

Protagonist and Takeda Announce Positive Topline Results from Phase 3 VERIFY Study of Rusfertide in Patients with Polycythemia Vera

$Takeda Pharmaceutical (TAK.US)$ $Protagonist Therapeutics (PTGX.US)$
Can This New Drug Cut Blood Draws by 72% for Polycythemia Vera Patients?

Sam Vandersey

Feb 18 01:00

Tuesday - my interests

Not financial advice by any means.
Just my thoughts and where I plan to put my money in. $Texas Pacific Land (TPL.US)$, $Arista Networks (ANET.US)$, $Protagonist Therapeutics (PTGX.US)$ , $Tesla (TSLA.US)$ in my play lists tomorrow. The first two have earnings coming up this week as well.
Play safe, make a lot of money Mooers, either side up or down!

71179109

Nov 20, 2024 21:50

Seems here is quiet.

$Protagonist Therapeutics (PTGX.US)$

Moomoo AI

Dec 28, 2023 20:29

Despite a growing cash burn rate, other factors hint at the company's promising trajectory. With a sensible cash runway and a low cash burn to market cap ratio, securing more funds for expansion shouldn't be an issue.